Guanze Medical and Funde HK Push Back Composite Offer Document Despatch to 17 April 2026

Bulletin Express04-10

Guanze Medical Information Industry (Holding) Co., Ltd. (Guanze Medical) and Funde (Hong Kong) Investment Holdings Co., Limited (Funde HK) have jointly announced a second postponement in sending out the composite document for Funde HK’s mandatory unconditional cash offer for all issued shares of Guanze Medical not already owned or to be acquired by Funde HK and its concert parties.

The parties were previously required to despatch the document by 10 April 2026, following an earlier extension disclosed on 4 March 2026. According to today’s filing, additional time is needed to complete certain sections—most notably the Independent Financial Adviser’s letter—necessitating a new deadline. An application under Rule 8.2 of the Hong Kong Takeovers Code has been submitted, and the Securities and Futures Commission’s Executive has indicated it is minded to approve an extension up to 17 April 2026.

Both companies will issue further announcements once the composite document and accompanying form of acceptance are dispatched or if there are any further timetable adjustments.

The statement reiterates that Guanze Medical’s board—comprising two executive, one non-executive and three independent non-executive directors—accepts responsibility for the accuracy of the company-related information, while Funde HK’s sole director assumes responsibility for the offeror-related information.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1139014001?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-10 19:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139014001","market":"hk","top_or_hot":-1,"title":"Guanze Medical and Funde HK Push Back Composite Offer Document Despatch to 17 April 2026","media":"Bulletin Express","content":"<p>Guanze Medical Information Industry (Holding) Co., Ltd. (Guanze Medical) and Funde (Hong Kong) Investment Holdings Co., Limited (Funde HK) have jointly announced a second postponement in sending out the composite document for Funde HK’s mandatory unconditional cash offer for all issued shares of Guanze Medical not already owned or to be acquired by Funde HK and its concert parties.</p>\n<p>The parties were previously required to despatch the document by 10 April 2026, following an earlier extension disclosed on 4 March 2026. According to today’s filing, additional time is needed to complete certain sections—most notably the Independent Financial Adviser’s letter—necessitating a new deadline. An application under Rule 8.2 of the Hong Kong Takeovers Code has been submitted, and the Securities and Futures Commission’s Executive has indicated it is minded to approve an extension up to 17 April 2026.</p>\n<p>Both companies will issue further announcements once the composite document and accompanying form of acceptance are dispatched or if there are any further timetable adjustments.</p>\n<p>The statement reiterates that Guanze Medical’s board—comprising two executive, one non-executive and three independent non-executive directors—accepts responsibility for the accuracy of the company-related information, while Funde HK’s sole director assumes responsibility for the offeror-related information.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guanze Medical and Funde HK Push Back Composite Offer Document Despatch to 17 April 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuanze Medical and Funde HK Push Back Composite Offer Document Despatch to 17 April 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-10 19:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guanze Medical Information Industry (Holding) Co., Ltd. (Guanze Medical) and Funde (Hong Kong) Investment Holdings Co., Limited (Funde HK) have jointly announced a second postponement in sending out the composite document for Funde HK’s mandatory unconditional cash offer for all issued shares of Guanze Medical not already owned or to be acquired by Funde HK and its concert parties.</p>\n<p>The parties were previously required to despatch the document by 10 April 2026, following an earlier extension disclosed on 4 March 2026. According to today’s filing, additional time is needed to complete certain sections—most notably the Independent Financial Adviser’s letter—necessitating a new deadline. An application under Rule 8.2 of the Hong Kong Takeovers Code has been submitted, and the Securities and Futures Commission’s Executive has indicated it is minded to approve an extension up to 17 April 2026.</p>\n<p>Both companies will issue further announcements once the composite document and accompanying form of acceptance are dispatched or if there are any further timetable adjustments.</p>\n<p>The statement reiterates that Guanze Medical’s board—comprising two executive, one non-executive and three independent non-executive directors—accepts responsibility for the accuracy of the company-related information, while Funde HK’s sole director assumes responsibility for the offeror-related information.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02427","symbol_name":"GUANZE MEDICAL","start_time":0,"source_url":"","article_id":"1139014001","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139014001","pubTimestamp":1775821397,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Guanze Medical Information Industry (Holding) Co., Ltd. (Guanze Medical) and Funde (Hong Kong) Investment Holdings Co., Limited (Funde HK) have jointly announced a second postponement in sending out...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02427":"GUANZE MEDICAL"},"translate_title":"冠泽医疗及富德香港将综合要约文件寄发推迟至2026年4月17日","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02427":1},"content_text":"Guanze Medical Information Industry (Holding) Co., Ltd. (Guanze Medical) and Funde (Hong Kong) Investment Holdings Co., Limited (Funde HK) have jointly announced a second postponement in sending out the composite document for Funde HK’s mandatory unconditional cash offer for all issued shares of Guanze Medical not already owned or to be acquired by Funde HK and its concert parties.\nThe parties were previously required to despatch the document by 10 April 2026, following an earlier extension disclosed on 4 March 2026. According to today’s filing, additional time is needed to complete certain sections—most notably the Independent Financial Adviser’s letter—necessitating a new deadline. An application under Rule 8.2 of the Hong Kong Takeovers Code has been submitted, and the Securities and Futures Commission’s Executive has indicated it is minded to approve an extension up to 17 April 2026.\nBoth companies will issue further announcements once the composite document and accompanying form of acceptance are dispatched or if there are any further timetable adjustments.\nThe statement reiterates that Guanze Medical’s board—comprising two executive, one non-executive and three independent non-executive directors—accepts responsibility for the accuracy of the company-related information, while Funde HK’s sole director assumes responsibility for the offeror-related information.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1139014001","isCrawlerRequest":true}